Global Autologous Stem Cell & Non-stem Cell Therapies Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Autologous Stem Cell & Non-stem Cell Therapies market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.
Autologous stem cell and non-stem cell therapies involve using a patient’s own cells to treat various medical conditions, offering personalized treatment options that minimize the risk of immune rejection and other complications.
This report is a detailed and comprehensive analysis for global Autologous Stem Cell & Non-stem Cell Therapies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Autologous Stem Cell & Non-stem Cell Therapies market size and forecasts, in consumption value ($ Million), 2020-2031
Global Autologous Stem Cell & Non-stem Cell Therapies market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Autologous Stem Cell & Non-stem Cell Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Autologous Stem Cell & Non-stem Cell Therapies market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Autologous Stem Cell & Non-stem Cell Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Autologous Stem Cell & Non-stem Cell Therapies market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anterogen Co., Ltd., APAC Biotech, Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.), Gilead Sciences, Inc., Green Cross Holdings Co., Ltd. (GC Cell), Healiva SA, ImmunoACT, Iaso Biotherapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Autologous Stem Cell & Non-stem Cell Therapies market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Autologous Stem Cell & Non-stem Cell Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Autologous Stem Cell & Non-stem Cell Therapies, with revenue, gross margin, and global market share of Autologous Stem Cell & Non-stem Cell Therapies from 2020 to 2025.
Chapter 3, the Autologous Stem Cell & Non-stem Cell Therapies competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Autologous Stem Cell & Non-stem Cell Therapies market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Autologous Stem Cell & Non-stem Cell Therapies.
Chapter 13, to describe Autologous Stem Cell & Non-stem Cell Therapies research findings and conclusion.
Autologous stem cell and non-stem cell therapies involve using a patient’s own cells to treat various medical conditions, offering personalized treatment options that minimize the risk of immune rejection and other complications.
This report is a detailed and comprehensive analysis for global Autologous Stem Cell & Non-stem Cell Therapies market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Autologous Stem Cell & Non-stem Cell Therapies market size and forecasts, in consumption value ($ Million), 2020-2031
Global Autologous Stem Cell & Non-stem Cell Therapies market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Autologous Stem Cell & Non-stem Cell Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Autologous Stem Cell & Non-stem Cell Therapies market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Autologous Stem Cell & Non-stem Cell Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Autologous Stem Cell & Non-stem Cell Therapies market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anterogen Co., Ltd., APAC Biotech, Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.), Gilead Sciences, Inc., Green Cross Holdings Co., Ltd. (GC Cell), Healiva SA, ImmunoACT, Iaso Biotherapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Autologous Stem Cell & Non-stem Cell Therapies market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- CAR-T
- Tumor Infiltrating Lymphocyte
- Hospital
- Surgery Center
- Other
- Anterogen Co., Ltd.
- APAC Biotech
- Bristol-Myers Squibb Company
- CARsgen Therapeutics Holdings Limited
- Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.)
- Gilead Sciences, Inc.
- Green Cross Holdings Co., Ltd. (GC Cell)
- Healiva SA
- ImmunoACT
- Iaso Biotherapeutics
- Johnson & Johnson
- Lovance Biotherapeutics, Inc.
- Novartis AG
- Pharmicell Co., Ltd.
- Regrow Biosciences Pvt Ltd.
- Tegoscience
- Vericel Corporation
- W (Cayman) Therapeutics Co. Ltd.
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Autologous Stem Cell & Non-stem Cell Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Autologous Stem Cell & Non-stem Cell Therapies, with revenue, gross margin, and global market share of Autologous Stem Cell & Non-stem Cell Therapies from 2020 to 2025.
Chapter 3, the Autologous Stem Cell & Non-stem Cell Therapies competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Autologous Stem Cell & Non-stem Cell Therapies market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Autologous Stem Cell & Non-stem Cell Therapies.
Chapter 13, to describe Autologous Stem Cell & Non-stem Cell Therapies research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Autologous Stem Cell & Non-stem Cell Therapies by Type
1.3.1 Overview: Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type in 2024
1.3.3 CAR-T
1.3.4 Tumor Infiltrating Lymphocyte
1.4 Global Autologous Stem Cell & Non-stem Cell Therapies Market by Application
1.4.1 Overview: Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Surgery Center
1.4.4 Other
1.5 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size & Forecast
1.6 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast by Region
1.6.1 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region, (2020-2031)
1.6.3 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
1.6.4 Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
1.6.6 South America Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Anterogen Co., Ltd.
2.1.1 Anterogen Co., Ltd. Details
2.1.2 Anterogen Co., Ltd. Major Business
2.1.3 Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.1.4 Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Anterogen Co., Ltd. Recent Developments and Future Plans
2.2 APAC Biotech
2.2.1 APAC Biotech Details
2.2.2 APAC Biotech Major Business
2.2.3 APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.2.4 APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 APAC Biotech Recent Developments and Future Plans
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business
2.3.3 Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.3.4 Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.4 CARsgen Therapeutics Holdings Limited
2.4.1 CARsgen Therapeutics Holdings Limited Details
2.4.2 CARsgen Therapeutics Holdings Limited Major Business
2.4.3 CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.4.4 CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 CARsgen Therapeutics Holdings Limited Recent Developments and Future Plans
2.5 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.)
2.5.1 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Details
2.5.2 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Major Business
2.5.3 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.5.4 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Recent Developments and Future Plans
2.6 Gilead Sciences, Inc.
2.6.1 Gilead Sciences, Inc. Details
2.6.2 Gilead Sciences, Inc. Major Business
2.6.3 Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.6.4 Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.7 Green Cross Holdings Co., Ltd. (GC Cell)
2.7.1 Green Cross Holdings Co., Ltd. (GC Cell) Details
2.7.2 Green Cross Holdings Co., Ltd. (GC Cell) Major Business
2.7.3 Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.7.4 Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Green Cross Holdings Co., Ltd. (GC Cell) Recent Developments and Future Plans
2.8 Healiva SA
2.8.1 Healiva SA Details
2.8.2 Healiva SA Major Business
2.8.3 Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.8.4 Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Healiva SA Recent Developments and Future Plans
2.9 ImmunoACT
2.9.1 ImmunoACT Details
2.9.2 ImmunoACT Major Business
2.9.3 ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.9.4 ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 ImmunoACT Recent Developments and Future Plans
2.10 Iaso Biotherapeutics
2.10.1 Iaso Biotherapeutics Details
2.10.2 Iaso Biotherapeutics Major Business
2.10.3 Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.10.4 Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Iaso Biotherapeutics Recent Developments and Future Plans
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.11.4 Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Johnson & Johnson Recent Developments and Future Plans
2.12 Lovance Biotherapeutics, Inc.
2.12.1 Lovance Biotherapeutics, Inc. Details
2.12.2 Lovance Biotherapeutics, Inc. Major Business
2.12.3 Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.12.4 Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Lovance Biotherapeutics, Inc. Recent Developments and Future Plans
2.13 Novartis AG
2.13.1 Novartis AG Details
2.13.2 Novartis AG Major Business
2.13.3 Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.13.4 Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Novartis AG Recent Developments and Future Plans
2.14 Pharmicell Co., Ltd.
2.14.1 Pharmicell Co., Ltd. Details
2.14.2 Pharmicell Co., Ltd. Major Business
2.14.3 Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.14.4 Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Pharmicell Co., Ltd. Recent Developments and Future Plans
2.15 Regrow Biosciences Pvt Ltd.
2.15.1 Regrow Biosciences Pvt Ltd. Details
2.15.2 Regrow Biosciences Pvt Ltd. Major Business
2.15.3 Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.15.4 Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Regrow Biosciences Pvt Ltd. Recent Developments and Future Plans
2.16 Tegoscience
2.16.1 Tegoscience Details
2.16.2 Tegoscience Major Business
2.16.3 Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.16.4 Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Tegoscience Recent Developments and Future Plans
2.17 Vericel Corporation
2.17.1 Vericel Corporation Details
2.17.2 Vericel Corporation Major Business
2.17.3 Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.17.4 Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Vericel Corporation Recent Developments and Future Plans
2.18 W (Cayman) Therapeutics Co. Ltd.
2.18.1 W (Cayman) Therapeutics Co. Ltd. Details
2.18.2 W (Cayman) Therapeutics Co. Ltd. Major Business
2.18.3 W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.18.4 W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 W (Cayman) Therapeutics Co. Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Autologous Stem Cell & Non-stem Cell Therapies Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Autologous Stem Cell & Non-stem Cell Therapies by Company Revenue
3.2.2 Top 3 Autologous Stem Cell & Non-stem Cell Therapies Players Market Share in 2024
3.2.3 Top 6 Autologous Stem Cell & Non-stem Cell Therapies Players Market Share in 2024
3.3 Autologous Stem Cell & Non-stem Cell Therapies Market: Overall Company Footprint Analysis
3.3.1 Autologous Stem Cell & Non-stem Cell Therapies Market: Region Footprint
3.3.2 Autologous Stem Cell & Non-stem Cell Therapies Market: Company Product Type Footprint
3.3.3 Autologous Stem Cell & Non-stem Cell Therapies Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value and Market Share by Type (2020-2025)
4.2 Global Autologous Stem Cell & Non-stem Cell Therapies Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2025)
5.2 Global Autologous Stem Cell & Non-stem Cell Therapies Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
6.2 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Application (2020-2031)
6.3 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country
6.3.1 North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2031)
6.3.2 United States Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
6.3.3 Canada Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
6.3.4 Mexico Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
7.2 Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2031)
7.3 Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country
7.3.1 Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2031)
7.3.2 Germany Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7.3.3 France Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7.3.5 Russia Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7.3.6 Italy Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region
8.3.1 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2020-2031)
8.3.2 China Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.3 Japan Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.4 South Korea Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.5 India Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.7 Australia Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
9.2 South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2031)
9.3 South America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country
9.3.1 South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2031)
9.3.2 Brazil Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
9.3.3 Argentina Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country
10.3.1 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2031)
10.3.2 Turkey Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
10.3.4 UAE Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Autologous Stem Cell & Non-stem Cell Therapies Market Drivers
11.2 Autologous Stem Cell & Non-stem Cell Therapies Market Restraints
11.3 Autologous Stem Cell & Non-stem Cell Therapies Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Autologous Stem Cell & Non-stem Cell Therapies Industry Chain
12.2 Autologous Stem Cell & Non-stem Cell Therapies Upstream Analysis
12.3 Autologous Stem Cell & Non-stem Cell Therapies Midstream Analysis
12.4 Autologous Stem Cell & Non-stem Cell Therapies Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Autologous Stem Cell & Non-stem Cell Therapies by Type
1.3.1 Overview: Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type in 2024
1.3.3 CAR-T
1.3.4 Tumor Infiltrating Lymphocyte
1.4 Global Autologous Stem Cell & Non-stem Cell Therapies Market by Application
1.4.1 Overview: Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Surgery Center
1.4.4 Other
1.5 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size & Forecast
1.6 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast by Region
1.6.1 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region, (2020-2031)
1.6.3 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
1.6.4 Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
1.6.6 South America Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Anterogen Co., Ltd.
2.1.1 Anterogen Co., Ltd. Details
2.1.2 Anterogen Co., Ltd. Major Business
2.1.3 Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.1.4 Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Anterogen Co., Ltd. Recent Developments and Future Plans
2.2 APAC Biotech
2.2.1 APAC Biotech Details
2.2.2 APAC Biotech Major Business
2.2.3 APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.2.4 APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 APAC Biotech Recent Developments and Future Plans
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business
2.3.3 Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.3.4 Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.4 CARsgen Therapeutics Holdings Limited
2.4.1 CARsgen Therapeutics Holdings Limited Details
2.4.2 CARsgen Therapeutics Holdings Limited Major Business
2.4.3 CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.4.4 CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 CARsgen Therapeutics Holdings Limited Recent Developments and Future Plans
2.5 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.)
2.5.1 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Details
2.5.2 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Major Business
2.5.3 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.5.4 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Recent Developments and Future Plans
2.6 Gilead Sciences, Inc.
2.6.1 Gilead Sciences, Inc. Details
2.6.2 Gilead Sciences, Inc. Major Business
2.6.3 Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.6.4 Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.7 Green Cross Holdings Co., Ltd. (GC Cell)
2.7.1 Green Cross Holdings Co., Ltd. (GC Cell) Details
2.7.2 Green Cross Holdings Co., Ltd. (GC Cell) Major Business
2.7.3 Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.7.4 Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Green Cross Holdings Co., Ltd. (GC Cell) Recent Developments and Future Plans
2.8 Healiva SA
2.8.1 Healiva SA Details
2.8.2 Healiva SA Major Business
2.8.3 Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.8.4 Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Healiva SA Recent Developments and Future Plans
2.9 ImmunoACT
2.9.1 ImmunoACT Details
2.9.2 ImmunoACT Major Business
2.9.3 ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.9.4 ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 ImmunoACT Recent Developments and Future Plans
2.10 Iaso Biotherapeutics
2.10.1 Iaso Biotherapeutics Details
2.10.2 Iaso Biotherapeutics Major Business
2.10.3 Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.10.4 Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Iaso Biotherapeutics Recent Developments and Future Plans
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.11.4 Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Johnson & Johnson Recent Developments and Future Plans
2.12 Lovance Biotherapeutics, Inc.
2.12.1 Lovance Biotherapeutics, Inc. Details
2.12.2 Lovance Biotherapeutics, Inc. Major Business
2.12.3 Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.12.4 Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Lovance Biotherapeutics, Inc. Recent Developments and Future Plans
2.13 Novartis AG
2.13.1 Novartis AG Details
2.13.2 Novartis AG Major Business
2.13.3 Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.13.4 Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Novartis AG Recent Developments and Future Plans
2.14 Pharmicell Co., Ltd.
2.14.1 Pharmicell Co., Ltd. Details
2.14.2 Pharmicell Co., Ltd. Major Business
2.14.3 Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.14.4 Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Pharmicell Co., Ltd. Recent Developments and Future Plans
2.15 Regrow Biosciences Pvt Ltd.
2.15.1 Regrow Biosciences Pvt Ltd. Details
2.15.2 Regrow Biosciences Pvt Ltd. Major Business
2.15.3 Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.15.4 Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Regrow Biosciences Pvt Ltd. Recent Developments and Future Plans
2.16 Tegoscience
2.16.1 Tegoscience Details
2.16.2 Tegoscience Major Business
2.16.3 Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.16.4 Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Tegoscience Recent Developments and Future Plans
2.17 Vericel Corporation
2.17.1 Vericel Corporation Details
2.17.2 Vericel Corporation Major Business
2.17.3 Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.17.4 Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Vericel Corporation Recent Developments and Future Plans
2.18 W (Cayman) Therapeutics Co. Ltd.
2.18.1 W (Cayman) Therapeutics Co. Ltd. Details
2.18.2 W (Cayman) Therapeutics Co. Ltd. Major Business
2.18.3 W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
2.18.4 W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 W (Cayman) Therapeutics Co. Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Autologous Stem Cell & Non-stem Cell Therapies Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Autologous Stem Cell & Non-stem Cell Therapies by Company Revenue
3.2.2 Top 3 Autologous Stem Cell & Non-stem Cell Therapies Players Market Share in 2024
3.2.3 Top 6 Autologous Stem Cell & Non-stem Cell Therapies Players Market Share in 2024
3.3 Autologous Stem Cell & Non-stem Cell Therapies Market: Overall Company Footprint Analysis
3.3.1 Autologous Stem Cell & Non-stem Cell Therapies Market: Region Footprint
3.3.2 Autologous Stem Cell & Non-stem Cell Therapies Market: Company Product Type Footprint
3.3.3 Autologous Stem Cell & Non-stem Cell Therapies Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value and Market Share by Type (2020-2025)
4.2 Global Autologous Stem Cell & Non-stem Cell Therapies Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2025)
5.2 Global Autologous Stem Cell & Non-stem Cell Therapies Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
6.2 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Application (2020-2031)
6.3 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country
6.3.1 North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2031)
6.3.2 United States Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
6.3.3 Canada Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
6.3.4 Mexico Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
7.2 Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2031)
7.3 Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country
7.3.1 Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2031)
7.3.2 Germany Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7.3.3 France Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7.3.5 Russia Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
7.3.6 Italy Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region
8.3.1 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2020-2031)
8.3.2 China Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.3 Japan Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.4 South Korea Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.5 India Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
8.3.7 Australia Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
9.2 South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2031)
9.3 South America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country
9.3.1 South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2031)
9.3.2 Brazil Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
9.3.3 Argentina Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country
10.3.1 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2031)
10.3.2 Turkey Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
10.3.4 UAE Autologous Stem Cell & Non-stem Cell Therapies Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Autologous Stem Cell & Non-stem Cell Therapies Market Drivers
11.2 Autologous Stem Cell & Non-stem Cell Therapies Market Restraints
11.3 Autologous Stem Cell & Non-stem Cell Therapies Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Autologous Stem Cell & Non-stem Cell Therapies Industry Chain
12.2 Autologous Stem Cell & Non-stem Cell Therapies Upstream Analysis
12.3 Autologous Stem Cell & Non-stem Cell Therapies Midstream Analysis
12.4 Autologous Stem Cell & Non-stem Cell Therapies Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Anterogen Co., Ltd. Company Information, Head Office, and Major Competitors
Table 6. Anterogen Co., Ltd. Major Business
Table 7. Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 8. Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Anterogen Co., Ltd. Recent Developments and Future Plans
Table 10. APAC Biotech Company Information, Head Office, and Major Competitors
Table 11. APAC Biotech Major Business
Table 12. APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 13. APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. APAC Biotech Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Company Major Business
Table 17. Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 18. Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. CARsgen Therapeutics Holdings Limited Company Information, Head Office, and Major Competitors
Table 20. CARsgen Therapeutics Holdings Limited Major Business
Table 21. CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 22. CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. CARsgen Therapeutics Holdings Limited Recent Developments and Future Plans
Table 24. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Company Information, Head Office, and Major Competitors
Table 25. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Major Business
Table 26. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 27. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Recent Developments and Future Plans
Table 29. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
Table 30. Gilead Sciences, Inc. Major Business
Table 31. Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 32. Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Gilead Sciences, Inc. Recent Developments and Future Plans
Table 34. Green Cross Holdings Co., Ltd. (GC Cell) Company Information, Head Office, and Major Competitors
Table 35. Green Cross Holdings Co., Ltd. (GC Cell) Major Business
Table 36. Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 37. Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Green Cross Holdings Co., Ltd. (GC Cell) Recent Developments and Future Plans
Table 39. Healiva SA Company Information, Head Office, and Major Competitors
Table 40. Healiva SA Major Business
Table 41. Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 42. Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Healiva SA Recent Developments and Future Plans
Table 44. ImmunoACT Company Information, Head Office, and Major Competitors
Table 45. ImmunoACT Major Business
Table 46. ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 47. ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. ImmunoACT Recent Developments and Future Plans
Table 49. Iaso Biotherapeutics Company Information, Head Office, and Major Competitors
Table 50. Iaso Biotherapeutics Major Business
Table 51. Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 52. Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Iaso Biotherapeutics Recent Developments and Future Plans
Table 54. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 55. Johnson & Johnson Major Business
Table 56. Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 57. Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Johnson & Johnson Recent Developments and Future Plans
Table 59. Lovance Biotherapeutics, Inc. Company Information, Head Office, and Major Competitors
Table 60. Lovance Biotherapeutics, Inc. Major Business
Table 61. Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 62. Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Lovance Biotherapeutics, Inc. Recent Developments and Future Plans
Table 64. Novartis AG Company Information, Head Office, and Major Competitors
Table 65. Novartis AG Major Business
Table 66. Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 67. Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Novartis AG Recent Developments and Future Plans
Table 69. Pharmicell Co., Ltd. Company Information, Head Office, and Major Competitors
Table 70. Pharmicell Co., Ltd. Major Business
Table 71. Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 72. Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Pharmicell Co., Ltd. Recent Developments and Future Plans
Table 74. Regrow Biosciences Pvt Ltd. Company Information, Head Office, and Major Competitors
Table 75. Regrow Biosciences Pvt Ltd. Major Business
Table 76. Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 77. Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Regrow Biosciences Pvt Ltd. Recent Developments and Future Plans
Table 79. Tegoscience Company Information, Head Office, and Major Competitors
Table 80. Tegoscience Major Business
Table 81. Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 82. Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Tegoscience Recent Developments and Future Plans
Table 84. Vericel Corporation Company Information, Head Office, and Major Competitors
Table 85. Vericel Corporation Major Business
Table 86. Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 87. Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Vericel Corporation Recent Developments and Future Plans
Table 89. W (Cayman) Therapeutics Co. Ltd. Company Information, Head Office, and Major Competitors
Table 90. W (Cayman) Therapeutics Co. Ltd. Major Business
Table 91. W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 92. W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. W (Cayman) Therapeutics Co. Ltd. Recent Developments and Future Plans
Table 94. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million) by Players (2020-2025)
Table 95. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Share by Players (2020-2025)
Table 96. Breakdown of Autologous Stem Cell & Non-stem Cell Therapies by Company Type (Tier 1, Tier 2, and Tier 3)
Table 97. Market Position of Players in Autologous Stem Cell & Non-stem Cell Therapies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 98. Head Office of Key Autologous Stem Cell & Non-stem Cell Therapies Players
Table 99. Autologous Stem Cell & Non-stem Cell Therapies Market: Company Product Type Footprint
Table 100. Autologous Stem Cell & Non-stem Cell Therapies Market: Company Product Application Footprint
Table 101. Autologous Stem Cell & Non-stem Cell Therapies New Market Entrants and Barriers to Market Entry
Table 102. Autologous Stem Cell & Non-stem Cell Therapies Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (USD Million) by Type (2020-2025)
Table 104. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Share by Type (2020-2025)
Table 105. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Forecast by Type (2026-2031)
Table 106. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025)
Table 107. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Forecast by Application (2026-2031)
Table 108. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 109. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 110. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 111. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 112. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 115. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 116. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 117. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 118. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2025) & (USD Million)
Table 119. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2026-2031) & (USD Million)
Table 120. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 121. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 122. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 123. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 124. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2020-2025) & (USD Million)
Table 125. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2026-2031) & (USD Million)
Table 126. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 127. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 128. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 129. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 130. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2025) & (USD Million)
Table 131. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2026-2031) & (USD Million)
Table 132. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 133. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 134. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 135. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 136. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2025) & (USD Million)
Table 137. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Global Key Players of Autologous Stem Cell & Non-stem Cell Therapies Upstream (Raw Materials)
Table 139. Global Autologous Stem Cell & Non-stem Cell Therapies Typical Customers
Table 1. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Anterogen Co., Ltd. Company Information, Head Office, and Major Competitors
Table 6. Anterogen Co., Ltd. Major Business
Table 7. Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 8. Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Anterogen Co., Ltd. Recent Developments and Future Plans
Table 10. APAC Biotech Company Information, Head Office, and Major Competitors
Table 11. APAC Biotech Major Business
Table 12. APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 13. APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. APAC Biotech Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Company Major Business
Table 17. Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 18. Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. CARsgen Therapeutics Holdings Limited Company Information, Head Office, and Major Competitors
Table 20. CARsgen Therapeutics Holdings Limited Major Business
Table 21. CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 22. CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. CARsgen Therapeutics Holdings Limited Recent Developments and Future Plans
Table 24. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Company Information, Head Office, and Major Competitors
Table 25. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Major Business
Table 26. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 27. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Recent Developments and Future Plans
Table 29. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
Table 30. Gilead Sciences, Inc. Major Business
Table 31. Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 32. Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Gilead Sciences, Inc. Recent Developments and Future Plans
Table 34. Green Cross Holdings Co., Ltd. (GC Cell) Company Information, Head Office, and Major Competitors
Table 35. Green Cross Holdings Co., Ltd. (GC Cell) Major Business
Table 36. Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 37. Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Green Cross Holdings Co., Ltd. (GC Cell) Recent Developments and Future Plans
Table 39. Healiva SA Company Information, Head Office, and Major Competitors
Table 40. Healiva SA Major Business
Table 41. Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 42. Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Healiva SA Recent Developments and Future Plans
Table 44. ImmunoACT Company Information, Head Office, and Major Competitors
Table 45. ImmunoACT Major Business
Table 46. ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 47. ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. ImmunoACT Recent Developments and Future Plans
Table 49. Iaso Biotherapeutics Company Information, Head Office, and Major Competitors
Table 50. Iaso Biotherapeutics Major Business
Table 51. Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 52. Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Iaso Biotherapeutics Recent Developments and Future Plans
Table 54. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 55. Johnson & Johnson Major Business
Table 56. Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 57. Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Johnson & Johnson Recent Developments and Future Plans
Table 59. Lovance Biotherapeutics, Inc. Company Information, Head Office, and Major Competitors
Table 60. Lovance Biotherapeutics, Inc. Major Business
Table 61. Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 62. Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Lovance Biotherapeutics, Inc. Recent Developments and Future Plans
Table 64. Novartis AG Company Information, Head Office, and Major Competitors
Table 65. Novartis AG Major Business
Table 66. Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 67. Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Novartis AG Recent Developments and Future Plans
Table 69. Pharmicell Co., Ltd. Company Information, Head Office, and Major Competitors
Table 70. Pharmicell Co., Ltd. Major Business
Table 71. Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 72. Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Pharmicell Co., Ltd. Recent Developments and Future Plans
Table 74. Regrow Biosciences Pvt Ltd. Company Information, Head Office, and Major Competitors
Table 75. Regrow Biosciences Pvt Ltd. Major Business
Table 76. Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 77. Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Regrow Biosciences Pvt Ltd. Recent Developments and Future Plans
Table 79. Tegoscience Company Information, Head Office, and Major Competitors
Table 80. Tegoscience Major Business
Table 81. Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 82. Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Tegoscience Recent Developments and Future Plans
Table 84. Vericel Corporation Company Information, Head Office, and Major Competitors
Table 85. Vericel Corporation Major Business
Table 86. Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 87. Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Vericel Corporation Recent Developments and Future Plans
Table 89. W (Cayman) Therapeutics Co. Ltd. Company Information, Head Office, and Major Competitors
Table 90. W (Cayman) Therapeutics Co. Ltd. Major Business
Table 91. W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product and Solutions
Table 92. W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. W (Cayman) Therapeutics Co. Ltd. Recent Developments and Future Plans
Table 94. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue (USD Million) by Players (2020-2025)
Table 95. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Share by Players (2020-2025)
Table 96. Breakdown of Autologous Stem Cell & Non-stem Cell Therapies by Company Type (Tier 1, Tier 2, and Tier 3)
Table 97. Market Position of Players in Autologous Stem Cell & Non-stem Cell Therapies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 98. Head Office of Key Autologous Stem Cell & Non-stem Cell Therapies Players
Table 99. Autologous Stem Cell & Non-stem Cell Therapies Market: Company Product Type Footprint
Table 100. Autologous Stem Cell & Non-stem Cell Therapies Market: Company Product Application Footprint
Table 101. Autologous Stem Cell & Non-stem Cell Therapies New Market Entrants and Barriers to Market Entry
Table 102. Autologous Stem Cell & Non-stem Cell Therapies Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (USD Million) by Type (2020-2025)
Table 104. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Share by Type (2020-2025)
Table 105. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Forecast by Type (2026-2031)
Table 106. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025)
Table 107. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Forecast by Application (2026-2031)
Table 108. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 109. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 110. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 111. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 112. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 115. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 116. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 117. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 118. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2025) & (USD Million)
Table 119. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2026-2031) & (USD Million)
Table 120. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 121. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 122. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 123. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 124. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2020-2025) & (USD Million)
Table 125. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Region (2026-2031) & (USD Million)
Table 126. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 127. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 128. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 129. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 130. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2025) & (USD Million)
Table 131. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2026-2031) & (USD Million)
Table 132. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2020-2025) & (USD Million)
Table 133. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type (2026-2031) & (USD Million)
Table 134. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2020-2025) & (USD Million)
Table 135. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application (2026-2031) & (USD Million)
Table 136. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2020-2025) & (USD Million)
Table 137. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Global Key Players of Autologous Stem Cell & Non-stem Cell Therapies Upstream (Raw Materials)
Table 139. Global Autologous Stem Cell & Non-stem Cell Therapies Typical Customers
LIST OF FIGURES
Figure 1. Autologous Stem Cell & Non-stem Cell Therapies Picture
Figure 2. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type in 2024
Figure 4. CAR-T
Figure 5. Tumor Infiltrating Lymphocyte
Figure 6. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application in 2024
Figure 8. Hospital Picture
Figure 9. Surgery Center Picture
Figure 10. Other Picture
Figure 11. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Market Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Region (2020-2031)
Figure 15. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Region in 2024
Figure 16. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 19. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Share by Players in 2024
Figure 23. Autologous Stem Cell & Non-stem Cell Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 24. Market Share of Autologous Stem Cell & Non-stem Cell Therapies by Player Revenue in 2024
Figure 25. Top 3 Autologous Stem Cell & Non-stem Cell Therapies Players Market Share in 2024
Figure 26. Top 6 Autologous Stem Cell & Non-stem Cell Therapies Players Market Share in 2024
Figure 27. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Share by Type (2020-2025)
Figure 28. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share Forecast by Type (2026-2031)
Figure 29. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Share by Application (2020-2025)
Figure 30. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share Forecast by Application (2026-2031)
Figure 31. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 32. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 33. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Country (2020-2031)
Figure 34. United States Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 38. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 41. France Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 46. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Region (2020-2031)
Figure 48. China Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 51. India Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 54. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 55. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 56. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 60. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Country (2020-2031)
Figure 62. Turkey Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 65. Autologous Stem Cell & Non-stem Cell Therapies Market Drivers
Figure 66. Autologous Stem Cell & Non-stem Cell Therapies Market Restraints
Figure 67. Autologous Stem Cell & Non-stem Cell Therapies Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Autologous Stem Cell & Non-stem Cell Therapies Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Autologous Stem Cell & Non-stem Cell Therapies Picture
Figure 2. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type in 2024
Figure 4. CAR-T
Figure 5. Tumor Infiltrating Lymphocyte
Figure 6. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application in 2024
Figure 8. Hospital Picture
Figure 9. Surgery Center Picture
Figure 10. Other Picture
Figure 11. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Market Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Region (2020-2031)
Figure 15. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Region in 2024
Figure 16. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 19. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Share by Players in 2024
Figure 23. Autologous Stem Cell & Non-stem Cell Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 24. Market Share of Autologous Stem Cell & Non-stem Cell Therapies by Player Revenue in 2024
Figure 25. Top 3 Autologous Stem Cell & Non-stem Cell Therapies Players Market Share in 2024
Figure 26. Top 6 Autologous Stem Cell & Non-stem Cell Therapies Players Market Share in 2024
Figure 27. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Share by Type (2020-2025)
Figure 28. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share Forecast by Type (2026-2031)
Figure 29. Global Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Share by Application (2020-2025)
Figure 30. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share Forecast by Application (2026-2031)
Figure 31. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 32. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 33. North America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Country (2020-2031)
Figure 34. United States Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 38. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 41. France Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 46. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Region (2020-2031)
Figure 48. China Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 51. India Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 54. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 55. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 56. South America Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Type (2020-2031)
Figure 60. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Consumption Value Market Share by Country (2020-2031)
Figure 62. Turkey Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE Autologous Stem Cell & Non-stem Cell Therapies Consumption Value (2020-2031) & (USD Million)
Figure 65. Autologous Stem Cell & Non-stem Cell Therapies Market Drivers
Figure 66. Autologous Stem Cell & Non-stem Cell Therapies Market Restraints
Figure 67. Autologous Stem Cell & Non-stem Cell Therapies Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Autologous Stem Cell & Non-stem Cell Therapies Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
